FMT
KYMR icon

First Mercantile Trust’s Kymera Therapeutics KYMR Stock Holding History

First Mercantile Trust’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$93K Sell
1,578
-150
-9% -$8.7K 0.01% 674
2021
Q2 		$84K Buy
1,728
+555
+47% +$24.1K 0.01% 729
2021
Q1 		$46K Sell
1,173
-227
-16% -$13.7K 0.01% 786
2020
Q4 		$87K Hold
1,400
– – 0.01% 719
2020
Q3 		$63K Buy
+1,400
New +$42.7K 0.01% 763

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

First Mercantile Trust's KYMR Position: Q3 2021 in Review

First Mercantile Trust reduced its Kymera Therapeutics (KYMR) stake by 8.7% in Q3 2021, selling an estimated $8.7K and leaving 1,578 shares worth $93K. The position accounts for 0.01% of the portfolio, ranked #674.

First Mercantile Trust first reported a position in KYMR in Q3 2020 and has held it in 5 quarters since. 115 funds tracked by Wall St. Rank hold KYMR as of Q3 2021.

  • First Mercantile Trust held 1,578 shares of Kymera Therapeutics worth $93K as of Q3 2021.
  • First Mercantile Trust sold 150 Kymera Therapeutics shares in Q3 2021, an estimated $8.7K.
  • Kymera Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #674 holding.
  • First Mercantile Trust first reported a position in Kymera Therapeutics in Q3 2020 and has held it in 5 quarters since.
  • 115 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.